Close Menu

London Stock Exchange

Osmetech is betting the five-year deal will expand its sales and marketing efforts in the US and allow it to allocate more resources towards bringing its pipeline of tests to market.

Life Technologies announced today that it has been named to the FTSE4 Good Index Series, which includes companies that reach rigorous social, ethical, and environmental criteria.

Industry Briefs: Mar 5, 2009

Premium

Bruker, NextGen, Sigma-Aldrich, Bio-Rad, Waters, Pressure BioSciences, PSI, Xencor, Pfizer

The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.

Tepnel's shareholders will vote on the deal next month, with the $132.1 million offer expected to take effect in April.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.